(688202)"Shanghai Medicilon Inc."Announcement on Cancellation of Certain Granted but Unvested 2025 Restricted Shares
Filed with SSE · Stock code 688202 · · 3 pages · Chinese
Summary by 6ix AI
The company stated that this cancellation will not materially affect its financial status or operational results. The board's compensation and assessment committee supported the decision, ensuring it aligns with legal and regulatory requirements.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Shanghai Medicilon, Inc. on 6ix
Story so far
- (688202)"Shanghai Medicilon Inc."Announcement on Shareholding Reduction Plan of Senior Executive
- (688202)"Shanghai Medicilon Inc."Announcement on Expiration of Shareholding Reduction Plan of Shareholder and Results of Shareholding Reduction
- (688202)"Shanghai Medicilon Inc."Announcement on Progress of Litigation Involving the Subsidiary
Earlier from Shanghai Medicilon
- (688202)"Shanghai Medicilon Inc."Announcement on Shareholding Reduction Plan of Senior Executive
- (688202)"Shanghai Medicilon Inc."Announcement on Expiration of Shareholding Reduction Plan of Shareholder and Results of Shareholding Reduction
- (688202)"Shanghai Medicilon Inc."Announcement on Progress of Litigation Involving the Subsidiary
- Indicative Announcement on Change in Equity Interests of Shareholder Reaching 1% Threshold
- Announcement on Progress of Litigation Involving the Subsidiary
Later from Shanghai Medicilon
All Shanghai Medicilon news releasesFollow Shanghai Medicilon into a list and get an email when it puts out news.
Follow Shanghai Medicilon